A BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE CEP of the European Pharmacopoeia monograph is often referred to as a BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE Certificate of Suitability (COS). The purpose of a BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE to their clients by showing that a BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE CEP has been issued for it. The manufacturer submits a BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE CEP (COS) as part of the market authorization procedure, and it takes on the role of a BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE CEP holder for the record. Additionally, the data presented in the BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE DMF.
A BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE suppliers with CEP (COS) on PharmaCompass.